Pediatrix Medical Group (NYSE:MD): A Value Stock Trading at a Discount With Solid Profitability
Pediatrix Medical Group (MD) Stock Looks Undervalued Despite Its 154% Run
Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026
3 Reasons MD is Risky and 1 Stock to Buy Instead
Pediatrix Medical Group (MD) Could Be 2% Below Fair Value Following Its Pullback
Pediatrix (MD) Grows Earnings Even As Patient Volumes Keep Falling
Q2 Earnings Highlights: Pediatrix Medical Group (NYSE:MD) Vs The Rest Of The Healthcare Providers & Services Stocks
Jefferies Downgrades Pediatrix Medical Group (MD)
Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28
Pediatrix Medical Group (NYSE:MD): A Value Stock with a Clear Margin of Safety
5 Must-Read Analyst Questions From Pediatrix Medical Group’s Q2 Earnings Call
Pediatrix Medical Group (MD) Q2 2026 Earnings Call Transcript
Pediatrix Medical Group (MD) Earnings Growth Puts Its Valuation Back In Focus
Is Stronger Q2 2026 EPS From Operations Altering The Investment Case For Pediatrix Medical Group (MD)?
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28
Pediatrix Medical Group Q2 Earnings Call Highlights
Pediatrix Medical Group, Inc. Q2 2026 Earnings Call Summary
Pediatrix Medical Group Inc (MD) (Q2 2026) Earnings Call Highlights: Strong EBITDA and Payer ...
Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call Transcript
Pediatrix Medical Group (NYSE:MD) Q2 EPS Beats Expectations, but Revenue Falls Just Short
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.